Mitochondrial dysfunctions and altered metals homeostasis: New weapons to counteract HCV-related oxidative stress

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Arciello, Mario ^a,b   Gori, Manuele ^b   Balsano, Clara ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Laboratory of Molecular Virology and Oncology Francesco Balsano Foundation   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METAL;

ANIMAL; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HUMAN; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY;

ANIMALS; HEPACIVIRUS; HEPATITIS C; HOMEOSTASIS; HUMANS; METALS; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84893837028     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/971024     Document Type: Review

References (128)

1. Hepatitis C. 2013, http://www.who.int/mediacentre/factsheets/fs164/en/
2. Lavanchy D., The global burden of hepatitis C. Liver International 2009 29 1 74 81 2-s2.0-59149085501 10.1111/j.1478-3231.2008.01934.x
3. Rosen H. R., Gretch D. R., Hepatitis C virus: current understanding and prospects for future therapies. Molecular Medicine Today 1999 5 9 393 399 2-s2.0-0032768206 10.1016/S1357-4310(99)01523-3 (Pubitemid 29399988)
4. Bartenschlager R., Penin F., Lohmann V., André P., Assembly of infectious hepatitis C virus particles. Trends in Microbiology 2011 19 2 95 103 2-s2.0-79952461113 10.1016/j.tim.2010.11.005
5. Farinati F., Cardin R., Bortolami M., Burra P., Russo F. P., Rugge M., Guido M., Sergio A., Naccarato R., Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. Journal of Viral Hepatitis 2007 14 12 821 829 2-s2.0-36749092354 10.1111/j.1365-2893.2007.00878.x (Pubitemid 350211406)
6. Arrese M., Riquelme A., Soza A., Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications. Annals of Hepatology 2010 9 1 112 118 2-s2.0-79952111965
7. Adinolfi L. E., Restivo L., Zampino R., Lonardo A., Loria P., Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opinion on Pharmacotherapy 2011 12 14 2215 2234 2-s2.0-80052620533 10.1517/14656566.2011. 597742
8. Guo C.-H., Chen P.-C., Lin K.-P., Shih M.-Y., Ko W.-S., Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects. Environmental Toxicology and Pharmacology 2012 33 2 288 296 2-s2.0-84855608795 10.1016/j.etap.2011.12.018
9. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006 160 1 1 40 2-s2.0-32444433202 10.1016/j.cbi.2005.12.009 (Pubitemid 43227479)
10. 2 signaling. Antioxidants and Redox Signaling 2011 14 3 459 468 2-s2.0-78650869592 10.1089/ars.2010.3363
11. Ryter S. W., Hong P. K., Hoetzel A., Park J. W., Nakahira K., Wang X., Choi A. M. K., Mechanisms of cell death in oxidative stress. Antioxidants and Redox Signaling 2007 9 1 49 89 2-s2.0-33845395850 10.1089/ars.2007.9.49 (Pubitemid 44901874)
12. Go Y.-M., Jones D. P., Redox compartmentalization in eukaryotic cells. Biochimica et Biophysica Acta 2008 1780 11 1273 1290 2-s2.0-49349085256 10.1016/j.bbagen.2008.01.011
13. de Mochel N. S. R., Seronello S., Wang S. H., Ito C., Zheng J. X., Liang T. J., Lambeth J. D., Choi J., Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 2010 52 1 47 59 2-s2.0-77954236285 10.1002/hep.23671
14. 2 a necessary evil for cell signaling. Science 2006 312 5782 1882 1883 2-s2.0-33745631769 10.1126/science.1130481 (Pubitemid 43993698)
15. Czaja M. J., Cell signaling in oxidative stress-induced liver injury. Seminars in Liver Disease 2007 27 4 378 389 2-s2.0-35948979743 10.1055/s-2007-991514 (Pubitemid 350071838)
16. Karbowski M., Youle R. J., Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death and Differentiation 2003 10 8 870 880 2-s2.0-0043166392 10.1038/sj.cdd.4401260 (Pubitemid 36939697)
17. Fujinaga H., Tsutsumi T., Yotsuyanagi H., Moriya K., Koike K., Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology 2011 81 1 11 17 2-s2.0-84855338121 10.1159/000333253
18. Mahmood S., Kawanaka M., Kamei A., Izumi A., Nakata K., Niiyama G., Ikeda H., Hanano S., Suehiro M., Togawa K., Yamada G., Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxidants and Redox Signaling 2004 6 1 19 24 2-s2.0-0346340016 (Pubitemid 38063973)
19. Konishi M., Iwasa M., Araki J., Kobayashi Y., Katsuki A., Sumida Y., Nakagawa N., Kojima Y., Watanabe S., Adachi Y., Kaito M., Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. Journal of Gastroenterology and Hepatology 2006 21 12 1821 1825 2-s2.0-33750097483 10.1111/j.1440-1746.2006.04420.x (Pubitemid 44657003)
20. Arciello M., Petta S., Leoni V., Iannucci G., Labbadia G., Cammà C., Craxì A., Balsano C., Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. Digestive and Liver Disease 2012 44 3 245 250 2-s2.0-84856586374 10.1016/j.dld.2011.10.022
21. Anticoli S., Arciello M., Mancinetti A., De Martinis M., Ginaldi L., Iuliano L., Balsano C., 7-Ketocholesterol and 5,6-secosterol modulate differently the stress-activated mitogen-activated protein kinases (MAPKs) in liver cells. Journal of Cellular Physiology 2010 222 3 586 595 2-s2.0-73649095857 10.1002/jcp.21972
22. Gelissen I. C., Rye K.-A., Brown A. J., Dean R. T., Jessup W., Oxysterol efflux from macrophage foam cells: the essential role of acceptor phospholipid. Journal of Lipid Research 1999 40 9 1636 1646 2-s2.0-0032841514 (Pubitemid 29418704)
23. Faulds M. H., Zhao C., Dahlman-Wright K., Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Current Opinion in Pharmacology 2010 10 6 692 697 2-s2.0-78149496368 10.1016/j.coph.2010.07.003
24. Koike K., Moriya K., Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. Journal of Gastroenterology 2005 40 4 329 336 2-s2.0-19444385812 10.1007/s00535-005-1586-z (Pubitemid 40723928)
25. Yadav D., Hertan H. I., Schweitzer P., Norkus E. P., Pitchumoni C. S., Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. American Journal of Gastroenterology 2002 97 10 2634 2639 2-s2.0-0036790718 10.1016/S0002-9270(02)04399-X
26. Fujita N., Sugimoto R., Ma N., Tanaka H., Iwasa M., Kobayashi Y., Kawanishi S., Watanabe S., Kaito M., Takei Y., Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. Journal of Viral Hepatitis 2008 15 7 498 507 2-s2.0-44849129329 10.1111/j.1365-2893.2008.00972.x (Pubitemid 351798987)
27. Kageyama F., Kobayashi Y., Kawasaki T., Toyokuni S., Uchida K., Nakamura H., Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. American Journal of Gastroenterology 2000 95 4 1041 1050 2-s2.0-0034113670 10.1016/S0002-9270(00) 00771-1 (Pubitemid 30196744)
28. Thorburn D., Curry G., Spooner R., Spence E., Oien K., Halls D., Fox R., McCruden E. A. B., MacSween R. N. M., Mills P. R., The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002 50 2 248 252 2-s2.0-0036155984 10.1136/gut.0500248. (Pubitemid 34087940)
29. Hézode C., Cazeneuve C., Coué O., Roudot-Thoraval F., Lonjon I., Bastie A., Duvoux C., Pawlotsky J.-M., Zafrani E.-S., Amselem S., Dhumeaux D., Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. Journal of Hepatology 1999 31 6 979 984 2-s2.0-0344129013 10.1016/S0168-8278(99)80308-0
30. Yuan L., Kaplowitz N., Glutathione in liver diseases and hepatotoxicity. Molecular Aspects of Medicine 2009 30 1-2 29 41 2-s2.0-65049085305 10.1016/j.mam.2008.08.003
31. Świtek K., Juszczyk J., Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. Journal of Viral Hepatitis 1997 4 2 139 141 2-s2.0-0031088467 (Pubitemid 127736549)
32. Barbaro G., Lorenzo G. D., Ribersani M., Soldini M., Giancaspro G., Bellomo G., Belloni G., Grisorio B., Barbarini G., Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. Journal of Hepatology 1999 30 5 774 782 2-s2.0-0033067273 10.1016/S0168-8278(99)80128-7 (Pubitemid 29248975)
33. Capone F., Guerriero E., Sorice A., Maio P., Colonna G., Castello G., Costantini S., Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients. Clinical Biochemistry 2012 45 7-8 525 529 2-s2.0-84860144758 10.1016/j.clinbiochem.2012.02.004
34. Levent G., Ali A., Ahmet A., Polat E. C., Aytaç Ç., Ayşe E., Ahmet S., Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. Journal of Translational Medicine 2006 4, article 25 2-s2.0-33746658598 10.1186/1479-5876-4-25 (Pubitemid 44144836)
35. Vendemiale G., Grattagliano I., Portincasa P., Serviddio G., Palasciamo G., Altomare E., Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up. European Journal of Clinical Investigation 2001 31 1 54 63 2-s2.0-0035138099 10.1046/j.1365-2362.2001.00747.x (Pubitemid 32151122)
36. Diamond D. L., Jacobs J. M., Paeper B., Proll S. C., Gritsenko M. A., Carithers R. L. Jr., Larson A. M., Yeh M. M., Camp D. G. II, Smith R. D., Katze M. G., Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology 2007 46 3 649 657 2-s2.0-34548788465 10.1002/hep.21751 (Pubitemid 47436109)
37. Sumida Y., Nakashima T., Yoh T., Nakajima Y., Ishikawa H., Mitsuyoshi H., Sakamoto Y., Okanoue T., Kashima K., Nakamura H., Yodoi J., Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. Journal of Hepatology 2000 33 4 616 622 2-s2.0-0033801679
38. Bessa S. S., Mohamed Ali E. M., Abd El-Wahab Ael S., Nor El-Din S. A., Heme oxygenase-1 mRNA expression in egyptian patients with chronic liver disease. Hepatitis Monthly 2012 12 278 285
39. Smirnova O. A., Ivanov A. V., Ivanova O. N., Valuev-Elliston V. T., Kochetkov S. N., Cell defense systems against oxidative stress and endoplasmic reticulum stress: mechanisms of regulation and the effect of hepatitis C virus. Molecular Biology 2011 45 1 110 122 2-s2.0-79951977937 10.1134/S0026893311010122
40. Aleksunes L. M., Manautou J. E., Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicologic Pathology 2007 35 4 459 473 2-s2.0-34250359779 10.1080/01926230701311344 (Pubitemid 46911886)
41. Burdette D., Olivarez M., Waris G., Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. Journal of General Virology 2010 91 3 681 690 2-s2.0-76849085285 10.1099/vir.0.014340-0
42. Goldenthal M. J., Marín-García J., Mitochondrial signaling pathways: a receiver/integrator organelle. Molecular and Cellular Biochemistry 2004 262 1-2 1 16 2-s2.0-4344693235 10.1023/B:MCBI.0000038228.85494.3b (Pubitemid 39158049)
43. Duchen M. R., Roles of mitochondria in health and disease. Diabetes 2004 53 1 S96 S102 2-s2.0-0842328798 (Pubitemid 38168700)
44. Barbaro G., Di Lorenzo G., Asti A., Ribersani M., Belloni G., Grisorio B., Filice G., Barbarini G., Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. American Journal of Gastroenterology 1999 94 8 2198 2205 2-s2.0-0033180064 10.1111/j.1572-0241.1999.01294.x (Pubitemid 29374554)
45. Yen H. H., Shih K. L., Lin T. T., Su W. W., Soon M. S., Liu C. S., Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. World Journal of Gastroenterology 2012 18 36 5084 5089
46. Rowland A. A., Voeltz G. K., Endoplasmic reticulum-mitochondria contacts: function of the junction. Nature Review Molecular Cell Biology 2012 13 10 607 625
47. Kinnally K. W., Peixoto P. M., Ryu S.-Y., Dejean L. M., Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochimica et Biophysica Acta 2011 1813 4 616 622 2-s2.0-79952702745 10.1016/j.bbamcr.2010.09.013
48. Rusiñol A. E., Cui Z., Chen M. H., Vance J. E., A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. Journal of Biological Chemistry 1994 269 44 27494 27502 2-s2.0-0027973135 (Pubitemid 24346578)
49. Popescu C.-I., Dubuisson J., Role of lipid metabolism in hepatitis C virus assembly and entry. Biology of the Cell 2010 102 1 63 74 2-s2.0-77956397284
50. Korenaga M., Wang T., Li Y., Showalter L. A., Chan T., Sun J., Weinman S. A., Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. Journal of Biological Chemistry 2005 280 45 37481 37488 2-s2.0-27844604269 10.1074/jbc.M506412200 (Pubitemid 41642356)
51. Kasprzak A., Seidel J., Biczysko W., Wysocki J., Spachacz R., Zabel M., Intracellular localization of NS3 and C proteins in chronic hepatitis C. Liver International 2005 25 4 896 903 2-s2.0-22844442887 10.1111/j.1478-3231.2005. 01109.x (Pubitemid 41038672)
52. Chu V. C., Bhattacharya S., Nomoto A., Lin J., Zaidi S. K., Oberley T. D., Weinman S. A., Azhar S., Huang T.-T., Persistent expression of hepatitis C virus non-structural proteins leads to increased autophagy and mitochondrial injury in human hepatoma cells. PLoS ONE 2011 6 12 2-s2.0-82555170658 10.1371/journal.pone.0028551 e28551
53. Schwer B., Ren S., Pietschmann T., Kartenbeck J., Kaehlcke K., Bartenschlager R., Yen T. S. B., Ott M., Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. Journal of Virology 2004 78 15 7958 7968 2-s2.0-3242673323 10.1128/JVI.78.15.7958-7968. 2004 (Pubitemid 38944281)
54. Suzuki R., Sakamoto S., Tsutsumi T., Rikimaru A., Tanaka K., Shimoike T., Moriishi K., Iwasaki T., Mizumoto K., Matsuura Y., Miyamura T., Suzuki T., Molecular determinants for subcellular localization of hepatitis C virus core protein. Journal of Virology 2005 79 2 1271 1281 2-s2.0-19944428289 10.1128/JVI.79.2.1271-1281.2005 (Pubitemid 40053909)
55. Wang T., Campbell R. V., Yi M. K., Lemon S. M., Weinman S. A., Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. Journal of Viral Hepatitis 2010 17 11 784 793 2-s2.0-79952197289
56. Wölk B., Sansonno D., Kräusslich H.-G., Dammacco F., Rice C. M., Blum H. E., Moradpour D., Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. Journal of Virology 2000 74 5 2293 2304 2-s2.0-0242456017 10.1128/JVI.74.5.2293-2304.2000 (Pubitemid 30091484)
57. Griffin S., Clarke D., McCormick C., Rowlands D., Harris M., Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes. Journal of Virology 2005 79 24 15525 15536 2-s2.0-29744467205 10.1128/JVI.79.24.15525-15536.2005 (Pubitemid 43032334)
58. Nomura-Takigawa Y., Nagano-Fujii M., Deng L., Kitazawa S., Ishido S., Sada K., Hotta H., Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. Journal of General Virology 2006 87 7 1935 1945 2-s2.0-33745624260 10.1099/vir.0.81701-0 (Pubitemid 43985876)
59. Horner S. M., Liu H. M., Park H. S., Briley J., Gale M. Jr., Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 2011 108 35 14590 14595 2-s2.0-80052281413 10.1073/pnas.1110133108
60. Galley H. F., Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Critical Care 2010 14 4, article 230 2-s2.0-79952115739 10.1186/cc9098
61. Murphy M. P., How mitochondria produce reactive oxygen species. Biochemical Journal 2009 417 1 1 13 2-s2.0-58249093939 10.1042/BJ20081386
62. Piccoli C., Scrima R., Quarato G., D'Aprile A., Ripoli M., Lecce L., Boffoli D., Moradpour D., Capitanio N., Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 2007 46 1 58 65 2-s2.0-34547415672 10.1002/hep.21679 (Pubitemid 47171921)
63. Ando M., Korenaga M., Hino K., Ikeda M., Kato N., Nishina S., Hidaka I., Sakaida I., Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication. Liver International 2008 28 8 1158 1166 2-s2.0-48949103979 10.1111/j.1478-3231. 2008.01720.x
64. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., Koike K., Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Research 2001 61 11 4365 4370 2-s2.0-0035360859 (Pubitemid 32685760)
65. Abdalla M. Y., Ahmad I. M., Spitz D. R., Schmidt W. N., Britigan B. E., Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. Journal of Medical Virology 2005 76 4 489 497 2-s2.0-21744438136 10.1002/jmv.20388 (Pubitemid 40943258)
66. Sayed H. A., El Ayyat A., El Dusoki H., Zoheiry M., Mohamed S., Hassan M., El Assaly N., Awad A., El Ansary M., Saad A., El Karim A. A., A cross sectional study of hepatitis B, C, some trace elements, heavy metals, aflatoxin B1 and schistosomiasis in a rural population, Egypt. The Journal of the Egyptian Public Health Association 2005 80 3-4 355 388 2-s2.0-33748124132
67. King J. C., Determinants of maternal zinc status during pregnancy. American Journal of Clinical Nutrition 2000 71 5 2-s2.0-0034013538
68. Oteiza P. I., Zinc and the modulation of redox homeostasis. Free Radical Biology and Medicine 2012 53 9 1748 1759
69. Rutter G. A., Think zinc: new roles for zinc in the control of insulin secretion. Islets 2010 2 1 49 50 2-s2.0-77953399221
70. Jomova K., Valko M., Advances in metal-induced oxidative stress and human disease. Toxicology 2011 283 2-3 65 87 2-s2.0-79954642381 10.1016/j.tox.2011. 03.001
71. Moradpour D., Penin F., Hepatitis C virus proteins: from structure to function. Current Topics in Microbiology and Immunology 2013 369 113 142
72. Himoto T., Hosomi N., Nakai S., Deguchi A., Kinekawa F., Matsuki M., Yachida M., Masaki T., Kurokochi K., Watanabe S., Senda S., Kuriyama S., Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scandinavian Journal of Gastroenterology 2007 42 9 1078 1087 2-s2.0-34548129234 10.1080/00365520701272409 (Pubitemid 47301142)
73. Murakami Y., Koyabu T., Kawashima A., Kakibuchi N., Kawakami T., Takaguchi K., Kita K., Okita M., Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon α -2b and ribavirin. Journal of Nutritional Science and Vitaminology 2007 53 3 213 218 2-s2.0-34547670935 10.3177/jnsv.53.213 (Pubitemid 47217217)
74. Prasad A. S., Zinc: role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition & Metabolic Care 2009 12 6 646 652 2-s2.0-70350126591 10.1097/MCO.0b013e3283312956
75. Kanda T., Yokosuka O., Nagao K., Saisho H., State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X. Cancer Letters 2006 234 2 143 148 2-s2.0-33645011764 10.1016/j.canlet.2005.03.030
76. Matsuoka S., Matsumura H., Nakamura H., Oshiro S., Arakawa Y., Hayashi J., Sekine N., Nirei K., Yamagami H., Ogawa M., Nakajima N., Amaki S., Tanaka N., Moriyama M., Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. Journal of Clinical Biochemistry and Nutrition 2009 45 3 292 303 2-s2.0-70549088924 10.3164/jcbn.jcbn08-246
77. Matsumura H., Nirei K., Nakamura H., Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. Journal of Clinical Biochemistry and Nutrition 2012 51 3 178 184
78. Yuasa K., Naganuma A., Sato K., Ikeda M., Kato N., Takagi H., Mori M., Zinc is a negative regulator of hepatitis C virus RNA replication. Liver International 2006 26 9 1111 1118 2-s2.0-33749589705 10.1111/j.1478-3231.2006. 01352.x (Pubitemid 44541752)
79. Cooper G. J., Selective divalent copper chelation for the treatment of diabetes mellitus. Current Medicinal Chemistry 2012 19 17 2828 2860
80. Li B., Tan Y., Sun W., Fu Y., Miao L., Cai L., The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. Toxicology Mechanisms and Methods 2013 23 1 27 33
81. Guo C. H., Chen P. C., Ko W. S., Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease. Internaional Journal of Medical Science 2013 10 6 730 737
82. Ko W.-S., Guo C.-H., Yeh M.-S., Lin L.-Y., Hsu G.-S. W., Chen P.-C., Luo M.-C., Lin C.-Y., Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World Journal of Gastroenterology 2005 11 30 4697 4702 2-s2.0-23844446272 (Pubitemid 41179526)
83. Roberts E. A., Schilsky M. L., Diagnosis and treatment of Wilson disease: an update. Hepatology 2008 47 6 2089 2111 2-s2.0-46249112793 10.1002/hep.22261 (Pubitemid 351945575)
84. Linder M. C., The relationship of copper to DNA damage and damage prevention in humans. Mutation Research 2012 733 1-2 83 91 2-s2.0-84860569809 10.1016/j.mrfmmm.2012.03.010
85. Mattie M. D., Freedman J. H., Copper-inducible transcription: regulation by metal- and oxidative stress-responsive pathways. American Journal of Physiology 2004 286 2 C293 C301 2-s2.0-0742323126 (Pubitemid 38146353)
86. Patel R. P., Darley-Usmar V. M., Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein. Free Radical Research 1999 30 1 1 9 2-s2.0-0033039534 (Pubitemid 29129408)
87. Nakhjavani M., Mashayekh A., Khalilzadeh O., Asgarani F., Morteza A., Omidi M., Froutan H., Oxidized low-density lipoprotein is associated with viral load and disease activity in patients with chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology 2011 35 2 111 116 2-s2.0-80052311780 10.1016/j.clinre.2010.11.001
88. Von Hahn T., Lindenbach B. D., Boullier A., Quehenberger O., Paulson M., Rice C. M., McKeating J. A., Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 2006 43 5 932 942 2-s2.0-33646573370 10.1002/hep.21139 (Pubitemid 43724618)
89. Westhaus S., Bankwitz D., Ernst S., Characterization of the inhibition of hepatitis C virus entry by In vitro-generated and patient-derived oxidized low-density lipoprotein. Hepatology 2013 57 5 1716 1724
90. Jones R. J., Lewis S. J., Smith J. M., Neuberger J., Undetectable serum caeruloplasmin in a woman with chronic hepatitis C infection. Journal of Hepatology 2000 32 4 703 704 2-s2.0-0034037309 10.1016/S0168-8278(00)80234-2 (Pubitemid 30180392)
91. Fillebeen C., Muckenthaler M., Andriopoulos B., Bisaillon M., Mounir Z., Hentze M. W., Koromilas A. E., Pantopoulos K., Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. Journal of Hepatology 2007 47 1 12 22 2-s2.0-34249278461 10.1016/j.jhep.2007.01.035 (Pubitemid 46817687)
92. Duygu F., Koruk S. T., Karsen H., Aksoy N., Taskin A., Hamidanoglu M., Prolidase and oxidative stress in chronic hepatitis C. Journal of Clinical Laboratory Analysis 2012 26 4 232 237
93. Anderson G. J., Wang F., Essential but toxic: controlling the flux of iron in the body. Clinical and Experimental Pharmacology and Physiology 2012 39 8 719 724
94. Martin D. N., Uprichard S. L., Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proceedings of the National Academy of Sciences of the United States of America 2013 110 26 10777 10782
95. Fontana R. J., Israel J., LeClair P., Banner B. F., Tortorelli K., Grace N., Levine R. A., Fiarman G., Thiim M., Tavill A. S., Bonkovsky H. L., Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 2000 31 3 730 736 2-s2.0-17544383347 (Pubitemid 30118643)
96. Hofer H., Österreicher C., Jessner W., Penz M., Steindl-Munda P., Wrba F., Ferenci P., Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. Journal of Hepatology 2004 40 6 1018 1022 2-s2.0-2442658823 10.1016/S0168-8278(04)00127-8 (Pubitemid 38670137)
97. Yano M., Hayashi H., Yoshioka K., Kohgo Y., Saito H., Niitsu Y., Kato J., Iino S., Yotsuyanagi H., Kobayashi Y., Kawamura K., Kakumu S., Kaito M., Ikoma J., Wakusawa S., Okanoue T., Sumida Y., Kimura F., Kajiwara E., Sata M., Ogata K., A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomised, controlled trial in Japan. Journal of Gastroenterology 2004 39 6 570 574 2-s2.0-3242887231 (Pubitemid 38996900)
98. Fujita N., Sugimoto R., Urawa N., Araki J., Mifuji R., Yamamoto M., Horiike S., Tanaka H., Iwasa M., Kobayashi Y., Adachi Y., Kaito M., Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. Journal of Gastroenterology and Hepatology 2007 22 11 1886 1893 2-s2.0-34948817771 10.1111/j.1440-1746.2006.04759.x (Pubitemid 47525078)
99. Lopez-Prieto J., Gonzalez-Reimers E., Aleman-Valls M. R., Iron and proinflammatory cytokines in chronic hepatitis C virus infection. Biological Trace Element Research 2013 155 1 5 10
100. Trinder D., Ayonrinde O. T., Olynyk J. K., HCV, iron, and oxidative stress: the new choreography of hepcidin. Gastroenterology 2008 134 1 348 351 2-s2.0-37349099045 10.1053/j.gastro.2007.11.048 (Pubitemid 350309353)
101. Nishina S., Hino K., Korenaga M., Vecchi C., Pietrangelo A., Mizukami Y., Furutani T., Sakai A., Okuda M., Hidaka I., Okita K., Sakaida I., Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008 134 1 226 238 2-s2.0-37349065804 10.1053/j.gastro.2007.10.011 (Pubitemid 350309316)
102. Liu H., Trinh T. L., Dong H., Keith R., Nelson D., Liu C., Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PLoS ONE 2012 7 10 e46631
103. Ivanov A. V., Bartosch B., Smirnova O. A., Isaguliants M. G., Kochetkov S. N., HCV and oxidative stress in the liver. Viruses 2013 5 2 439 469
104. Furutani T., Hino K., Okuda M., Gondo T., Nishina S., Kitase A., Korenaga M., Xiao S.-Y., Weinman S. A., Lemon S. M., Sakaida I., Okita K., Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006 130 7 2087 2098 2-s2.0-33744512454 10.1053/j.gastro.2006.02.060 (Pubitemid 43816966)
105. Huang M. L.-H., Lane D. J. R., Richardson D. R., Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease. Antioxidants and Redox Signaling 2011 15 12 3003 3019 2-s2.0-80155135813 10.1089/ars.2011.3921
106. Leary S. C., Redox regulation of SCO protein function: controlling copper at a mitochondrial crossroad. Antioxidants and Redox Signaling 2010 13 9 1403 1416 2-s2.0-77957085271 10.1089/ars.2010.3116
107. Pawlotsky J. M., Treatment of chronic hepatitis C: current and future. Current Topics in Microbiology and Immunology 2013 369 321 342
108. Casey L. C., Lee W. M., Hepatitis C virus therapy update 2013. Current Opinion in Gastroenterology 2013 29 3 243 249
109. Seronello S., Montanez J., Presleigh K., Barlow M., Park S. B., Choi J., Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals. PLoS ONE 2011 6 11 2-s2.0-80555129637 10.1371/journal.pone.0027436 e27436
110. Smith R. A. J., Porteous C. M., Gane A. M., Murphy M. P., Delivery of bioactive molecules to mitochondria in vivo. Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5407 5412 2-s2.0-0037965634 10.1073/pnas.0931245100 (Pubitemid 36542718)
111. Murphy M. P., Smith R. A. J., Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annual Review of Pharmacology and Toxicology 2007 47 629 656 2-s2.0-33847071146 10.1146/annurev.pharmtox.47.120505.105110
112. Jauslin M. L., Meier T., Smith R. A. J., Murphy M. P., Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB Journal 2003 17 1972 1974
113. Gane E. J., Weilert F., Orr D. W., Keogh G. F., Gibson M., Lockhart M. M., Frampton C. M., Taylor K. M., Smith R. A. J., Murphy M. P., The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver International 2010 30 7 1019 1026 2-s2.0-77956496245 10.1111/j.1478-3231.2010.02250.x
114. Gallay P. A., Cyclophilin Inhibitors. Clinics in Liver Disease 2009 13 3 403 417 2-s2.0-67650566582 10.1016/j.cld.2009.05.002
115. Paeshuyse J., Kaul A., De Clercq E., Rosenwirth B., Dumont J.-M., Scalfaro P., Bartenschlager R., Neyts J., The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 2006 43 4 761 770 2-s2.0-33646015668 10.1002/hep.21102
116. Crabbé R., Vuagniaux G., Dumont J.-M., Nicolas-Métral V., Marfurt J., Novaroli L., An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C. Expert Opinion on Investigational Drugs 2009 18 2 211 220 2-s2.0-65549151252 10.1517/ 13543780802651583
117. Coelmont L., Kaptein S., Paeshuyse J., Vliegen I., Dumont J.-M., Vuagniaux G., Neyts J., Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors. Antimicrobial Agents and Chemotherapy 2009 53 3 967 976 2-s2.0-62949181285 10.1128/AAC.00939-08
118. Gallay P. A., Lin K., Profile of alisporivir and its potential in the treatment of hepatitis C. Journal of Drug Design, Development and Therapy 2013 7 105 115
119. Quarato G., D'Aprile A., Gavillet B., Vuagniaux G., Moradpour D., Capitanio N., Piccoli C., The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction. Hepatology 2012 55 5 1333 1343 2-s2.0-84859995274 10.1002/hep.25514
120. Grüngreiff K., Reinhold D., Zinc: a complementary factor in the treatment of chronic hepatitis C? (Review). Molecular Medicine Reports 2010 3 3 371 375 2-s2.0-77952347108 10.3892/mmr-00000267
121. Fargion S., Ludovica Fracanzani A., Sampietro M., Molteni V., Boldorini R., Mattioli M., Cesana B., Lunghi G., Piperno A., Valsecchi C., Fiorelli G., Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. European Journal of Gastroenterology and Hepatology 1997 9 5 497 503 2-s2.0-8244248790 (Pubitemid 27214456)
122. Calland N., Dubuisson J., Rouille Y., Seron K., Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 2012 4 10 2197 2217
123. Zatloukalová M., Křen V., Gažák R., Kubala M., Trouillas P., Ulrichová J., Vacek J., Electrochemical investigation of flavonolignans and study of their interactions with DNA in the presence of Cu(II). Bioelectrochemistry 2011 82 2 117 124 2-s2.0-80053117099 10.1016/j.bioelechem.2011.06.005
124. Rossi L., Mazzitelli S., Arciello M., Capo C. R., Rotilio G., Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochemical Research 2008 33 12 2390 2400 2-s2.0-56349157854 10.1007/s11064-008-9696-7
125. Han D. S., Hahm B., Rho H.-M., Jang S. K., Identification of the protease domain in NS3 of hepatitis C virus. Journal of General Virology 1995 76 4 985 993 2-s2.0-0028960558
126. Bartolomei G., Cevik R. E., Marcello A., Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes. Journal of General Virology 2011 92 9 2072 2081 2-s2.0-80051739560 10.1099/vir.0.032706-0
127. Choi J., Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radical Biology and Medicine 2012 52 7 1135 1150 2-s2.0-84857911244 10.1016/j.freeradbiomed.2012.01.008
128. Perron N. R., García C. R., Pinzón J. R., Chaur M. N., Brumaghim J. L., Antioxidant and prooxidant effects of polyphenol compounds on copper-mediated DNA damage. Journal of Inorganic Biochemistry 2011 105 5 745 753 2-s2.0-79953678405 10.1016/j.jinorgbio.2011.02.009